偏头痛治疗设备市场－全球产业规模、份额、趋势、机会和预测，按类型、部位、产品类型、疗法、配销通路、最终用户、地区和竞争格局划分，2020-2030年预测

2024年全球偏头痛治疗设备市场规模为7.4964亿美元，预计到2030年将以8.54%的复合年增长率增长至12.2572亿美元。该市场涵盖旨在缓解或预防偏头痛的专用医疗器械，主要采用神经刺激等非药物疗法。推动该市场成长的关键因素是全球偏头痛盛行率的不断上升，从而需要有效的治疗方案。

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球偏头痛治疗设备市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依类型（体外三叉神经刺激（e-TNS）装置、单脉衝经颅磁刺激器（sTMS）、gammaCore非侵入式迷走神经刺激器、其他）
  • 依使用地点（手持式、头戴式、其他）
  • 依产品类型（处方药、非处方药）
  • 依治疗方法（急性治疗、预防治疗）
  • 按配销通路（医院药房、零售药房、网路药房）
  • 按最终使用者（医院和诊所、家庭护理、其他）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美偏头痛治疗设备市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲偏头痛治疗设备市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区偏头痛治疗设备市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲偏头痛治疗设备市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲偏头痛治疗设备市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购（如有）
• 产品发布（如有）
• 最新进展

第十三章：全球偏头痛治疗设备市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Theranica Bio-Electronics Ltd.
• CEFALY Technology SPRL
• ElectroCore, Inc.
• eNeura Inc.
• Neurolief Ltd.
• Cirrus Healthcare Products LLC
• Neuros Medical Inc.
• Salvia BioElectronics BV
• Theranica Bio-Electronics Ltd.
• Dr Reddy's Laboratories Ltd.

第十六章：策略建议

第17章调查会社について・免责事项

The Global Migraine Treatment Devices Market, valued at USD 749.64 Million in 2024, is projected to experience a CAGR of 8.54% to reach USD 1225.72 Million by 2030. The Global Migraine Treatment Devices Market encompasses specialized medical instruments designed to alleviate or prevent migraine headaches, primarily employing non-pharmacological approaches such as neurostimulation. A key driver for this market is the increasing global prevalence of migraine disorders, necessitating effective management solutions.

Key Market Drivers

The increasing global migraine prevalence constitutes a primary driver for the migraine treatment devices market, generating a substantial and expanding patient demographic in need of effective therapeutic options. Migraine, a debilitating neurological disorder, profoundly impacts quality of life and productivity, prompting individuals to seek diverse management solutions. The rising incidence globally underscores an urgent demand for innovative and accessible treatments, including non-pharmacological device-based therapies. According to 'The Global Burden of Migraine: A 30-Year Trend Review and Future Projections by Age, Sex, Country, and Region' published in Pain Ther. , December 2024, the global prevalence of migraine reached 1.16 billion cases in 2021, illustrating the immense number of individuals affected. This extensive burden necessitates the adoption of varied treatment modalities, fueling the market for specialized devices.

Key Market Challenges

A significant challenge impeding the growth of the Global Migraine Treatment Devices Market is the limited reimbursement coverage for these specialized instruments in various regions. This directly impacts market expansion by restricting patient access and hindering affordability. When innovative non-pharmacological migraine therapies, such as neurostimulation devices, lack comprehensive insurance coverage, patients often face substantial out-of-pocket costs. This financial burden can deter individuals from adopting these treatments, even when clinically appropriate.

Key Market Trends

The Global Migraine Treatment Devices Market is being significantly shaped by two distinct, influential trends. The first involves a growing patient preference for non-invasive devices. Patients increasingly seek therapeutic options that circumvent the side effects and complexities often associated with pharmacological treatments. This shift fosters demand for user-friendly, non-pharmacological alternatives for migraine management. According to MedTech Europe, the European medical device market recorded a growth rate of 2.4% in 2023, reflecting a broader acceptance and integration of diverse medical devices, including non-invasive options, into patient care. This preference is further demonstrated by real-world data, where 64.2% of school-aged participants effectively managed their migraine symptoms using the Nerivio REN wearable, a discreet, non-drug treatment, as reported by Theranica in December 2024. This indicates a strong inclination towards devices that offer effective relief without medication.

Key Market Players

• Theranica Bio-Electronics Ltd.
• CEFALY Technology SPRL
• ElectroCore, Inc.
• eNeura Inc.
• Neurolief Ltd.
• Cirrus Healthcare Products LLC
• Neuros Medical Inc.
• Salvia BioElectronics B.V.
• Theranica Bio-Electronics Ltd.
• Dr Reddy's Laboratories Ltd.

Report Scope:

In this report, the Global Migraine Treatment Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Migraine Treatment Devices Market, By Type:

• External Trigeminal Nerve Stimulation (e-TNS) Device
• Single Pulse Transcranial Magnetic Stimulator (sTMS)
• gammaCore Non-Invasive Vagus Nerve Stimulator
• Others

Migraine Treatment Devices Market, By Site:

• Handheld
• Headband
• Others

Migraine Treatment Devices Market, By Product Type:

• Prescription
• Over The Counter

Migraine Treatment Devices Market, By Therapy:

• Acute Therapy
• Preventive Therapy

Migraine Treatment Devices Market, By Distribution Channel:

• Hospital Based Pharmacies
• Retail Pharmacies
• Online Pharmacies

Migraine Treatment Devices Market, By End User:

• Hospitals & Clinics
• Homecare
• Others

Migraine Treatment Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Migraine Treatment Devices Market.

Available Customizations:

Global Migraine Treatment Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Migraine Treatment Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (External Trigeminal Nerve Stimulation (e-TNS) Device, Single Pulse Transcranial Magnetic Stimulator (sTMS), gammaCore Non-Invasive Vagus Nerve Stimulator, Others)
  • 5.2.2. By Site (Handheld, Headband, Others)
  • 5.2.3. By Product Type (Prescription, Over The Counter)
  • 5.2.4. By Therapy (Acute Therapy, Preventive Therapy)
  • 5.2.5. By Distribution Channel (Hospital Based Pharmacies, Retail Pharmacies, Online Pharmacies)
  • 5.2.6. By End User (Hospitals & Clinics, Homecare, Others)
  • 5.2.7. By Region
  • 5.2.8. By Company (2024)
• 5.3. Market Map

6. North America Migraine Treatment Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Site
  • 6.2.3. By Product Type
  • 6.2.4. By Therapy
  • 6.2.5. By Distribution Channel
  • 6.2.6. By End User
  • 6.2.7. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Migraine Treatment Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Site
      • 6.3.1.2.3. By Product Type
      • 6.3.1.2.4. By Therapy
      • 6.3.1.2.5. By Distribution Channel
      • 6.3.1.2.6. By End User
  • 6.3.2. Canada Migraine Treatment Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Site
      • 6.3.2.2.3. By Product Type
      • 6.3.2.2.4. By Therapy
      • 6.3.2.2.5. By Distribution Channel
      • 6.3.2.2.6. By End User
  • 6.3.3. Mexico Migraine Treatment Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Site
      • 6.3.3.2.3. By Product Type
      • 6.3.3.2.4. By Therapy
      • 6.3.3.2.5. By Distribution Channel
      • 6.3.3.2.6. By End User

7. Europe Migraine Treatment Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Site
  • 7.2.3. By Product Type
  • 7.2.4. By Therapy
  • 7.2.5. By Distribution Channel
  • 7.2.6. By End User
  • 7.2.7. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Migraine Treatment Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Site
      • 7.3.1.2.3. By Product Type
      • 7.3.1.2.4. By Therapy
      • 7.3.1.2.5. By Distribution Channel
      • 7.3.1.2.6. By End User
  • 7.3.2. France Migraine Treatment Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Site
      • 7.3.2.2.3. By Product Type
      • 7.3.2.2.4. By Therapy
      • 7.3.2.2.5. By Distribution Channel
      • 7.3.2.2.6. By End User
  • 7.3.3. United Kingdom Migraine Treatment Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Site
      • 7.3.3.2.3. By Product Type
      • 7.3.3.2.4. By Therapy
      • 7.3.3.2.5. By Distribution Channel
      • 7.3.3.2.6. By End User
  • 7.3.4. Italy Migraine Treatment Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Site
      • 7.3.4.2.3. By Product Type
      • 7.3.4.2.4. By Therapy
      • 7.3.4.2.5. By Distribution Channel
      • 7.3.4.2.6. By End User
  • 7.3.5. Spain Migraine Treatment Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Site
      • 7.3.5.2.3. By Product Type
      • 7.3.5.2.4. By Therapy
      • 7.3.5.2.5. By Distribution Channel
      • 7.3.5.2.6. By End User

8. Asia Pacific Migraine Treatment Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Site
  • 8.2.3. By Product Type
  • 8.2.4. By Therapy
  • 8.2.5. By Distribution Channel
  • 8.2.6. By End User
  • 8.2.7. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Migraine Treatment Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Site
      • 8.3.1.2.3. By Product Type
      • 8.3.1.2.4. By Therapy
      • 8.3.1.2.5. By Distribution Channel
      • 8.3.1.2.6. By End User
  • 8.3.2. India Migraine Treatment Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Site
      • 8.3.2.2.3. By Product Type
      • 8.3.2.2.4. By Therapy
      • 8.3.2.2.5. By Distribution Channel
      • 8.3.2.2.6. By End User
  • 8.3.3. Japan Migraine Treatment Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Site
      • 8.3.3.2.3. By Product Type
      • 8.3.3.2.4. By Therapy
      • 8.3.3.2.5. By Distribution Channel
      • 8.3.3.2.6. By End User
  • 8.3.4. South Korea Migraine Treatment Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Site
      • 8.3.4.2.3. By Product Type
      • 8.3.4.2.4. By Therapy
      • 8.3.4.2.5. By Distribution Channel
      • 8.3.4.2.6. By End User
  • 8.3.5. Australia Migraine Treatment Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Site
      • 8.3.5.2.3. By Product Type
      • 8.3.5.2.4. By Therapy
      • 8.3.5.2.5. By Distribution Channel
      • 8.3.5.2.6. By End User

9. Middle East & Africa Migraine Treatment Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Site
  • 9.2.3. By Product Type
  • 9.2.4. By Therapy
  • 9.2.5. By Distribution Channel
  • 9.2.6. By End User
  • 9.2.7. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Migraine Treatment Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Site
      • 9.3.1.2.3. By Product Type
      • 9.3.1.2.4. By Therapy
      • 9.3.1.2.5. By Distribution Channel
      • 9.3.1.2.6. By End User
  • 9.3.2. UAE Migraine Treatment Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Site
      • 9.3.2.2.3. By Product Type
      • 9.3.2.2.4. By Therapy
      • 9.3.2.2.5. By Distribution Channel
      • 9.3.2.2.6. By End User
  • 9.3.3. South Africa Migraine Treatment Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Site
      • 9.3.3.2.3. By Product Type
      • 9.3.3.2.4. By Therapy
      • 9.3.3.2.5. By Distribution Channel
      • 9.3.3.2.6. By End User

10. South America Migraine Treatment Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Site
  • 10.2.3. By Product Type
  • 10.2.4. By Therapy
  • 10.2.5. By Distribution Channel
  • 10.2.6. By End User
  • 10.2.7. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Migraine Treatment Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Site
      • 10.3.1.2.3. By Product Type
      • 10.3.1.2.4. By Therapy
      • 10.3.1.2.5. By Distribution Channel
      • 10.3.1.2.6. By End User
  • 10.3.2. Colombia Migraine Treatment Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Site
      • 10.3.2.2.3. By Product Type
      • 10.3.2.2.4. By Therapy
      • 10.3.2.2.5. By Distribution Channel
      • 10.3.2.2.6. By End User
  • 10.3.3. Argentina Migraine Treatment Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Site
      • 10.3.3.2.3. By Product Type
      • 10.3.3.2.4. By Therapy
      • 10.3.3.2.5. By Distribution Channel
      • 10.3.3.2.6. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Migraine Treatment Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Theranica Bio-Electronics Ltd.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. CEFALY Technology SPRL
• 15.3. ElectroCore, Inc.
• 15.4. eNeura Inc.
• 15.5. Neurolief Ltd.
• 15.6. Cirrus Healthcare Products LLC
• 15.7. Neuros Medical Inc.
• 15.8. Salvia BioElectronics B.V.
• 15.9. Theranica Bio-Electronics Ltd.
• 15.10. Dr Reddy's Laboratories Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer